[{"id":"jak2","kind":"target","name":"JAK2","route":"/targets/jak2/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/gap-fill.ts","type":"changed","fields":[{"field":"biology","before":"\"Non-receptor tyrosine kinase with a pseudokinase (JH2) domain that normally restrains the kinase (JH1); V617F in JH2 relieves autoinhibition, causing cytokine-independent STAT5/MAPK/PI3K signalling and erythroid/mega...","after":"\"JAK2 is a non-receptor tyrosine kinase with a pseudokinase (JH2) domain that normally restrains the kinase (JH1); V617F in JH2 relieves autoinhibition, causing cytokine-independent STAT5/MAPK/PI3K signalling and eryt..."}]},{"id":"jak2","kind":"target","name":"JAK2","route":"/targets/jak2/","commit":"71e4eef6e1","date":"2026-09-08","author":"Jude Gomila","message":"Gap audit and gap-fill data: 33 cancers, 87 products, 20 targets, 25 technologies, 12 terms, 18 collections","file":"src/data/gap-fill.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"symbol"},{"field":"targetClass"},{"field":"wikipedia"},{"field":"tldr"},{"field":"summary"},{"field":"biology"},{"field":"whereFound"},{"field":"prevalence"},{"field":"cancers"},{"field":"drugs"},{"field":"technologies"},{"field":"pathways"},{"field":"links"},{"field":"tags"}]}]